← Leaderboards
Dat Quang Tran
Oryn Therapeutics, Llc
$4,753,792
Attributed
$4,753,792
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2015–22$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,753,792 · 2
By mechanism
R44$4,753,792 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Protocols Documentation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$562,015,656
- Lawrence Corey · Fred Hutchinson Cancer Center$498,533,651
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Judith S. Currier · University Of California Los Angeles$445,196,577
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$381,639,813
Research focus
Protocols DocumentationSmall Business Innovation Research GrantPreparationTheta-DefensinResponseSafety StudyInjectableInfectionPharmacodynamicsPharmaceutical PreparationsRattusApplications GrantsCyclic GmpSafetyDoseDrug KineticsImmunocompromised HostBiologicalIn VivoLeadCanis FamiliarisPeptidesPeptide DrugFormulation
Grant awards (6)
Cyclic Orynotides for Systemic MDR Candidiasis$983,348
R44 · FY2022 · AI · contact PI
Cyclic Orynotides for Systemic MDR Candidiasis$991,551
R44 · FY2021 · AI · contact PI
Cyclic Orynotides for Systemic MDR Candidiasis$998,632
R44 · FY2020 · AI · contact PI
Cyclic Orynotides for Systemic MDR Candidiasis$284,978
R44 · FY2019 · AI · contact PI
First-in-Class Macrocyclic Peptide Therapeutic For Rheumatoid Arthritis$352,749
R44 · FY2016 · AR · contact PI
First-in-Class Macrocyclic Peptide Therapeutic For Rheumatoid Arthritis$1,142,534
R44 · FY2015 · AR · contact PI